Results 11 to 20 of about 41 (40)

The microbiome in cancer

iMeta, Volume 4, Issue 5, October 2025.
This comprehensive review elucidates the transformative role of the human microbiome in cancer biology, revealing innovative mechanistic insights into the intricate tumor–microbe interactions across diverse organ systems. This work highlights the clinical and translational value of novel microbiome‐based biomarkers for early detection, prognosis, and ...
Anqi Lin, Minying Xiong, Aimin Jiang, Lihaoyun Huang, Hank Z. H. Wong, Suyin Feng, Chunyan Zhang, Yu Li, Li Chen, Hao Chi, Pengpeng Zhang, Bicheng Ye, Hengguo Zhang, Nan Zhang, Lingxuan Zhu, Weiming Mou, Junyi Shen, Kailai Li, Wentao Xu, Haoxuan Ying, Cangang Zhang, Dongqiang Zeng, Jindong Xie, Xinpei Deng, Qi Wang, Jianying Xu, Wenjie Shi, Chang Qi, Chunrun Qu, Xufeng Huang, András Hajdu, Chaoqun Li, Changmin Peng, Xuanye Cao, Guangsheng Pei, Lin Zhang, Yujia Huo, Jiabao Xu, Antonino Glaviano, Attila Gábor Szöllősi, Sicheng Bian, Zhengrui Li, Hailin Tang, Bufu Tang, Zaoqu Liu, Jian Zhang, Kai Miao, Quan Cheng, Ting Wei, Shuofeng Yuan, Peng Luo   +50 more
wiley   +1 more source

Five‐Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment

Journal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2560-2567, October 2025.
ABSTRACT Background and Aim Long‐term nucleos(t)ide analog (NUC) therapy is essential for chronic hepatitis B (CHB) management. However, data on long‐term outcomes, particularly for patients switching to tenofovir alafenamide (TAF) and patients with chronic kidney disease (CKD), remain limited.
Eiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi, Kazufumi Dohmen, Aritsune Ooho, Akira Kawano, Norihiro Furusyo, Eiji Kajiwara, Takeaki Satoh, Kazuhiro Takahashi, Koichi Azuma, Rie Sugimoto, Yasunori Ichiki, Takeshi Senju, Hiromasa Amagase, Masatake Tanaka, Makoto Nakamuta, Hideyuki Nomura, Jun Hayashi, The Kyushu University Liver Disease Study (KULDS) Group   +19 more
wiley   +1 more source

Creating Biomimetic Bouligand Architectures for Biomedical and Healthcare Applications

Interdisciplinary Materials, Volume 4, Issue 4, Page 539-567, July 2025.
Hierarchical Bouligand structures, evolved in nature for mechanical/functional advantages, are now replicated via various of strategies, including self‐assembly, biomimetic mineralization, shear brushing, electrostatic spinning, 3D printing, etc. Engineered architectures enable breakthroughs in bone regeneration, tooth repair, body protection, and ...
Hongye Yang, Xinyu Zhang, Shilei Wang, Yize Wang, Rui Xiong, Cui Huang   +5 more
wiley   +1 more source

Christian Bohr. Discoverer of Homotropic and Heterotopic Allostery

Acta Physiologica, Volume 241, Issue S734, July 2025.
ABSTRACT This essay recounts and revisits the scientific contributions of Christian Bohr, highlighting his pivotal role in discovering allostery about 120 years ago. Bohr's meticulous experimentation led to identifying two distinct forms of allostery: homotropic (single‐ligand) and heterotropic (multi‐ligand), the latter widely recognized as the Bohr ...
Niels Bindslev
wiley   +1 more source

Facial Temperature Responses to Ostracism in Women: Exploring Nasal Thermal Signatures of Different Coping Behaviors

Psychophysiology, Volume 62, Issue 6, June 2025.
ABSTRACT Ostracism (feeling ignored and excluded) triggers psychophysiological responses associated with distress. We investigated different coping responses after ostracism and explored whether these were preceded by unique facial thermal signatures, reflecting autonomic nervous system (ANS) activity. Using thermal infrared imaging, we recorded facial
Anneloes Kip, Thorsten M. Erle, Ilja van Beest   +2 more
wiley   +1 more source

Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Objectives To compare the efficacy and safety of sedation with midazolam and remimazolam for colorectal endoscopy. Methods This single‐center, two‐arm, post‐hoc analysis of the REM‐IICTJP01 study investigated the efficacy and safety of remimazolam for gastrointestinal endoscopic sedation.
Kanako Ogura, Ryoji Ichijima, Hisatomo Ikehara, Tomomi Sugita, Daisuke Yamaguchi, Yasuhiko Nagata, Mitsuru Esaki, Yosuke Minoda, Hiroyuki Ono, Kinichi Hotta, Shinsuke Kiriyama, Tetsuya Sumiyoshi, Yuichi Kanmura   +12 more
wiley   +1 more source

Usefulness and safety of remimazolam in upper gastrointestinal endoscopy: A comparative study between elderly and non‐elderly patients

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Objectives In gastroenterology, sedation demand is increasing, although elderly patients are more prone to experiencing adverse events. Remimazolam, a novel ultra‐short‐acting benzodiazepine, may reduce recovery time after endoscopic procedures. Methods This study was a secondary analysis of the investigator‐initiated trial, which investigated
Ryoji Ichijima, Hisatomo Ikehara, Daisuke Yamaguchi, Yasuhiko Nagata, Kanako Ogura, Mitsuru Esaki, Yosuke Minoda, Hiroyuki Ono, Yuki Maeda, Shinsuke Kiriyama, Tetsuya Sumiyoshi, Yuichi Kanmura   +11 more
wiley   +1 more source

Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction

Cancer Science, Volume 116, Issue 2, Page 559-563, February 2025.
Signaling lymphocytic activation molecule family 7 (SLAMF7), an important therapeutic target of myeloma cells, is highly expressed in osteoclasts. Ex vivo‐expanded human Vγ9Vδ2 T cells are able to efficaciously exert antibody‐dependent cellular cytotoxicity (ADCC) with the anti‐SLAMF7 monoclonal antibody elotuzumab for SLAMF7‐expressing myeloma cells ...
Yusuke Inoue, Hirofumi Tenshin, Jumpei Teramachi, Ryohei Sumitani, Asuka Oda, Yusaku Maeda, Masahiro Oura, Kimiko Sogabe, Tomoko Maruhashi, Mamiko Takahashi, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Tomoyo Hara, Itsuro Endo, Kumiko Kagawa, Shuji Ozaki, Masahiro Hiasa, Takeshi Harada, Masahiro Abe   +19 more
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

UEG Week 2025 Oral Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S7-S188, October 2025.
wiley   +1 more source